Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats

Neuropharmacology

Volumn 57, Issue 4, 2009, Pages 403-408

  Yamamoto, Hiroko ^a   Shimoshige, Yukinori ^a   Yamaji, Takayuki ^a   Murai, Nobuhito ^a   Aoki, Toshiaki ^a   Matsuoka, Nobuya ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Mechanical allodynia; Neuropathic pain; Painful diabetic neuropathy (PDN); Streptozotocin (STZ)

Indexed keywords

AMITRIPTYLINE; DICLOFENAC; MEXILETINE; MORPHINE; PREGABALIN;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; LOCOMOTION; MALE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ANALGESICS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; MALE; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 68749112451     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.06.037     Document Type: Article

References (37)

1. Ahlgren S.C., and Levine J.D. Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained. Brain Res. 616 (1993) 171-175
2. Arner S., and Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33 (1988) 11-23
3. Attal N. Chronic neuropathic pain: mechanisms and treatment. Clin. J. Pain 16 (2000) S118-S130
4. Banning M. The use of topical diclofenac for pain in osteoarthritis of the knee: a review. Br. J. Community Nurs. 11 (2006) 487-492
5. Bitar M.S., and DeSouza E.B. Diabetes-related changes in brain beta adrenoreceptors in rats as assessed by quantitative autoradiography: relationship to hypothalamic norepinephrine metabolism and pituitary-gonadal hormone secretion. J. Pharmacol. Exp. Ther. 254 (1990) 781-785
6. Chen S.R., and Pan H.L. Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J. Neurophysiol. 87 (2002) 2726-2733
7. Chen S.R., Sweigart K.L., Lakoski J.M., and Pan H.L. Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology 97 (2002) 1602-1608
8. Chong M.S., and Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs 67 (2007) 569-585
9. Coudore F., Besson A., Courteix C., Eschalier A., Lavarenne J., and Fialip J. Pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites in streptozocin-induced diabetic rats. Gen. Pharmacol. 27 (1996) 803-807
10. Coudore F., Fialip J., Eschalier A., and Lavarenne J. Plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after acute intraperitoneal injection in mice. Eur. J. Drug Metab. Pharmacokinet. 19 (1994) 5-11
11. Courteix C., Bourget P., Caussade F., Bardin M., Coudore F., Fialip J., and Eschalier A. Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?. J. Pharmacol. Exp. Ther. 285 (1998) 63-70
12. Courteix C., Eschalier A., and Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53 (1993) 81-88
13. Craner M.J., Klein J.P., Renganathan M., Black J.A., and Waxman S.G. Changes of sodium channel expression in experimental painful diabetic neuropathy. Ann. Neurol. 52 (2002) 786-792
14. Dobretsov M., Hastings S.L., Romanovsky D., Stimers J.R., and Zhang J.M. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res. 960 (2003) 174-183
15. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., Wilson D.M., O'Brien P.C., Melton III L.J., and Service F.J. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43 (1993) 817-824
16. Galzin A.M., Moret C., Verzier B., and Langer S.Z. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus. J. Pharmacol. Exp. Ther. 235 (1985) 200-211
17. Garry E.M., Delaney A., Anderson H.A., Sirinathsinghji E.C., Clapp R.H., Martin W.J., Kinchington P.R., Krah D.L., Abbadie C., and Fleetwood-Walker S.M. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 118 (2005) 97-111
18. Harati Y. Diabetes and the nervous system. Endocrinol. Metab. Clin. North Am. 25 (1996) 325-359
19. Hoybergs Y.M., Biermans R.L., and Meert T.F. The impact of bodyweight and body condition on behavioral testing for painful diabetic neuropathy in the streptozotocin rat model. Neurosci. Lett. 436 (2008) 13-18
20. Hughes I.E. The effect of amitriptyline on presynaptic mechanisms in noradrenergic nerves. Br. J. Pharmacol. 63 (1978) 315-321
21. Jarvis B., and Coukell A.J. Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs 56 (1998) 691-707
22. Kiguchi S., Imamura T., Ichikawa K., and Kojima M. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Clin. Exp. Pharmacol. Physiol. 31 (2004) 57-64
23. Lackovic Z., Salkovic M., Kuci Z., and Relja M. Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J. Neurochem. 54 (1990) 143-147
24. Li C.Y., Song Y.H., Higuera E.S., and Luo Z.D. Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J. Neurosci. 24 (2004) 8494-8499
25. Miyake K., Fukuchi H., Kitaura T., Kimura M., Sarai K., and Nakahara T. Pharmacokinetics of amitriptyline and its demethylated metabolite in serum and specific brain regions of rats after acute and chronic administration of amitriptyline. J. Pharm. Sci. 79 (1990) 288-291
26. Nielsen C.K., Ross F.B., Lotfipour S., Saini K.S., Edwards S.R., and Smith M.T. Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain 132 (2007) 289-300
27. Petrisic M.S., Augood S.J., and Bicknell R.J. Monoamine transporter gene expression in the central nervous system in diabetes mellitus. J. Neurochem. 68 (1997) 2435-2441
28. Smith T., and Nicholson R.A. Review of duloxetine in the management of diabetic peripheral neuropathic pain. Vasc. Health Risk Manag. 3 (2007) 833-844
29. Stahl S.M. Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators. J. Clin. Psychiatry 65 (2004) 1033-1034
30. Stracke H., Meyer U.E., Schumacher H.E., and Federlin K. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 15 (1992) 1550-1555
31. Sugimoto K., Rashid I.B., Shoji M., Suda T., and Yasujima M. Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats. J. Pain 9 (2008) 237-245
32. Tesfaye S., and Kempler P. Painful diabetic neuropathy. Diabetologia 48 (2005) 805-807
33. Trulson M.E., Jacoby J.H., and MacKenzie R.G. Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats. J. Neurochem. 46 (1986) 1068-1072
34. Ulugol A., Karadag H.C., Tamer M., Firat Z., Aslantas A., and Dokmeci I. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Neurosci. Lett. 328 (2002) 129-132
35. Williams J., Haller V.L., Stevens D.L., and Welch S.P. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception. Eur. J. Pharmacol. 584 (2008) 78-86
36. Wuarin-Bierman L., Zahnd G.R., Kaufmann F., Burcklen L., and Adler J. Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia 30 (1987) 653-658
37. Yusaf S.P., Goodman J., Gonzalez I.M., Bramwell S., Pinnock R.D., Dixon A.K., and Lee K. Streptozocin-induced neuropathy is associated with altered expression of voltage-gated calcium channel subunit mRNAs in rat dorsal root ganglion neurones. Biochem. Biophys. Res. Commun. 289 (2001) 402-406